Teva Pharmaceuticals · 7 hours ago
Vice President, Business Development, Search & Initial Evaluation
Parsippany, NJ
Full-time
Hybrid
Director/Executive
10+ years expTeva Pharmaceuticals is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. The company is seeking a dynamic and visionary Vice President of Search and Initial Evaluation to lead strategic growth initiatives, focusing on identifying and securing external partnerships within the pharmaceutical landscape.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Proactively identify and assess external innovation opportunities (e.g., assets, platforms, technologies) in core therapeutic areas: CNS, I&I diseases, and rare diseases aligned to Teva’s Pivot to Growth strategy
Significantly increase the volume and breadth of sourced opportunities, while ensuring alignment with the company’s strategic and scientific priorities—improving the quality and quantity of assets that progress to advanced evaluation and potential deal discussions
Build and maintain deep relationships across the biotech and pharmaceutical ecosystem, including with academic institutions, investors, incubators, and early-stage companies
Collaborate closely with internal stakeholders (R&D, commercial, legal, finance) to perform scientific, strategic, and commercial assessments of potential external opportunities
Build and manage a high-performing, business development search team, with strong scientific foundations fostering a culture of innovation and accountability
Lead the initial due diligence process for high-priority opportunities, including data review, competitive landscaping, and risk/benefit analysis
Strategically represent the company externally at scientific and business development conferences, staying abreast of relevant innovation and competitive activity
Contribute to the development of partnership and licensing strategies, including co-development and co-commercialization opportunities
Lead, manage, and develop a high-performing Search & Initial Evaluation team, ensuring strong execution, consistent quality, and broad coverage of external innovation
Set priorities, allocate resources, and guide team members in identifying, evaluating, and presenting external opportunities
Establish best practices for opportunity triage, cross-functional collaboration, and documentation of scientific and strategic rationale
Qualification
Required
Ph.D., M.D., or advanced degree in life sciences or medicine required
Minimum of 10+ years of experience in the biotech/pharmaceutical industry, with at least 5 years in business development, search & evaluation, or related roles
Demonstrated expertise in CNS, inflammation, immunology, and rare diseases is strongly preferred
Proven track record of identifying and evaluating innovative external assets and leading cross-functional teams through early diligence
Strong experience in managing and mentoring teams, with demonstrated ability to lead through influence and vision
Deep understanding of drug development processes, from discovery to commercialization
Strong industry network and existing relationships with biotech companies, academic institutions, investors, and KOLs
Excellent analytical, strategic thinking, and communication skills
High degree of agility, initiative, and creativity; able to navigate ambiguity and adapt quickly to evolving priorities
Ability to thrive in a collaborative, entrepreneurial, and mission-driven environment
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase